Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Oct 30 - Nov 4
The toxin resembled glucagon, a hormone that raises blood sugar, so, scientists named it glucagon-like-peptide 1, or GLP-1. In the early 2000s, we got our first medical breakthrough with GLP-1, a drug called exenatide (Byetta) approved for the treatment of type 2 diabetes
The first experiment in this study showed a few parameters of chromatin after peptide treatment
Diabetes 49, 424430 (2000)
Our structure reveals the role of the C-domain loop of IGF1 in receptor binding
Opioid-Related Pathways Animal work suggests that some DSIP effects may involve endogenous opioid signalling
US$ 28.28
US$ 21.27
US$ 29.40
US$ 28.03
US$ 24.42
